Mangalam Drugs & Organics Limited (NSE:MANGALAM)

India flag India · Delayed Price · Currency is INR
73.98
-2.30 (-3.02%)
May 6, 2025, 3:29 PM IST
-26.97%
Market Cap 1.22B
Revenue (ttm) 3.47B
Net Income (ttm) 101.91M
Shares Out n/a
EPS (ttm) 6.44
PE Ratio 11.96
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 15,451
Average Volume 23,780
Open 77.12
Previous Close 76.28
Day's Range 73.00 - 77.32
52-Week Range 72.01 - 144.99
Beta 0.97
RSI 40.15
Earnings Date May 30, 2025

About Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers API products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, ... [Read more]

Sector Healthcare
Founded 1972
Employees 432
Stock Exchange National Stock Exchange of India
Ticker Symbol MANGALAM
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.